Skip to main content
Screener/Healthcare/Biotechnology

NAGE Niagen Bioscience Inc

NASDAQ
$4.20+0.01 (+0.12%)
$4.04
$14.69
$4.04
$4.26
EPS (TTM)$0.20
P/E Ratio20.56
Dividend Yield
Market Cap$386.0M
Volume1.29M
Prev Close$4.19
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$33.8M$4.1M$0.0564.1%12.2%
Q3 '25$34.0M$4.6M$0.0564.5%13.5%
Q2 '25$31.1M$3.6M$0.0465.0%11.6%
Q1 '25$30.5M$5.1M$0.0663.4%16.6%
Q4 '24$29.1M$7.2M$0.0962.5%24.6%
Q3 '24$25.6M$1.9M$0.0263.5%7.3%
Q2 '24$22.7M-$15K$-0.0060.2%-0.1%
Q1 '24$22.2M-$492K$-0.0160.7%-2.2%
Get Your Daily Market Recap